Reid IR - Search Results

1

Reid IR, Green JR, Lyles KW, Reid DM, Trechsel U, Hosking DJ, Black DM, Cummings SR, Russell RGG, Eriksen EF. Reid IR, et al. Among authors: reid dm. Bone. 2020 Aug;137:115390. doi: 10.1016/j.bone.2020.115390. Epub 2020 Apr 27. Bone. 2020. PMID: 32353565

2

Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.

Garton M, Reid I, Loveridge N, Robins S, Murchison L, Beckett G, Reid D. Garton M, et al. Clin Endocrinol (Oxf). 1994 Dec;41(6):747-55. doi: 10.1111/j.1365-2265.1994.tb02789.x. Clin Endocrinol (Oxf). 1994. PMID: 7889610

3

Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ. Reid IR, et al. N Engl J Med. 2002 Feb 28;346(9):653-61. doi: 10.1056/NEJMoa011807. N Engl J Med. 2002. PMID: 11870242 Free article. Clinical Trial.

4

Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.

Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T. Reid IR, et al. Bone. 2004 Jul;35(1):224-30. doi: 10.1016/j.bone.2004.03.023. Bone. 2004. PMID: 15207761

5

beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.

Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC. Reid IR, et al. J Bone Miner Res. 2005 Apr;20(4):613-8. doi: 10.1359/JBMR.041202. Epub 2004 Dec 6. J Bone Miner Res. 2005. PMID: 15765180 Free article.

6

Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial.

Reid IR, Tonkin A, Cannon CP. Reid IR, et al. Bone. 2005 Aug;37(2):190-1. doi: 10.1016/j.bone.2005.04.012. Bone. 2005. PMID: 15936996

7

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D. Reid IR, et al. N Engl J Med. 2005 Sep 1;353(9):898-908. doi: 10.1056/NEJMoa044241. N Engl J Med. 2005. PMID: 16135834 Free article. Clinical Trial.

8

Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR. Hosking D, et al. Among authors: reid ir. J Bone Miner Res. 2007 Jan;22(1):142-8. doi: 10.1359/jbmr.061001. J Bone Miner Res. 2007. PMID: 17032148 Free article. Clinical Trial.

9

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: reid ir. J Clin Endocrinol Metab. 2007 Apr;92(4):1283-8. doi: 10.1210/jc.2006-2216. Epub 2007 Jan 16. J Clin Endocrinol Metab. 2007. PMID: 17227801 Clinical Trial.

10

Zoledronate: efficacy and safety.

Reid IR. Reid IR. J Bone Miner Res. 2006 Dec;21 Suppl 2:P83-7. doi: 10.1359/jbmr.06s215. J Bone Miner Res. 2006. PMID: 17229014 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

510 results

Search Page